Thyradin


Indications and Reactions:

Role Indications Reactions
Secondary
Hypothyroidism 17.6%
Product Used For Unknown Indication 16.2%
Inflammation 8.1%
Pain 6.8%
Hypertension 5.4%
Asthma 4.1%
Gastritis 4.1%
Growth Hormone-producing Pituitary Tumour 4.1%
Pituitary Tumour 4.1%
Reflux Oesophagitis 4.1%
Renal Transplant 4.1%
Rheumatoid Arthritis 4.1%
Constipation 2.7%
Diarrhoea 2.7%
Drug Use For Unknown Indication 2.7%
Pyrexia 2.7%
Renal Failure 2.7%
Angina Pectoris 1.4%
Breast Cancer 1.4%
Cardiovascular Disorder 1.4%
Rhabdomyolysis 13.3%
Liver Disorder 10.0%
Urine Ketone Body Present 10.0%
Hypertension 6.7%
Thalamus Haemorrhage 6.7%
Vomiting 6.7%
Blood Alkaline Phosphatase Increased 3.3%
Blood Calcium Decreased 3.3%
Delirium 3.3%
Dermatitis Exfoliative 3.3%
Diverticulum Intestinal Haemorrhagic 3.3%
Embolism Venous 3.3%
Gait Disturbance 3.3%
Hypercalcaemia 3.3%
Hypoalbuminaemia 3.3%
Hypocalcaemia 3.3%
Hypotension 3.3%
Hypothyroidism 3.3%
Inappropriate Schedule Of Drug Administration 3.3%
Intestinal Ischaemia 3.3%
Concomitant
Hypertension 10.9%
Metastatic Renal Cell Carcinoma 10.0%
Product Used For Unknown Indication 9.1%
Hypothyroidism 8.9%
Rheumatoid Arthritis 7.9%
Prophylaxis 7.8%
Cardiac Failure 6.1%
Castleman's Disease 5.0%
Drug Use For Unknown Indication 4.8%
Constipation 3.6%
Chronic Hepatitis C 3.3%
Gastritis 3.0%
Cardiac Failure Chronic 3.0%
Osteoporosis 2.6%
Glaucoma 2.5%
Depression 2.4%
Insomnia 2.4%
Diabetes Mellitus 2.3%
Renal Cell Carcinoma 2.2%
Atrial Fibrillation 2.0%
White Blood Cell Count Decreased 9.8%
Rash 8.2%
Pyrexia 7.5%
Stomatitis 6.3%
Vomiting 6.3%
Interstitial Lung Disease 5.9%
Renal Failure Acute 5.9%
Renal Impairment 5.9%
Platelet Count Decreased 5.5%
White Blood Cell Count Increased 4.7%
Renal Failure Chronic 4.3%
Hepatic Function Abnormal 3.9%
Weight Increased 3.9%
Death 3.1%
Hypoglycaemia 3.1%
Malaise 3.1%
Neutrophil Count Decreased 3.1%
Pneumonia 3.1%
Pneumonia Aspiration 3.1%
Shock 3.1%

Drug Data